Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 6 Warts 1 Neoplasms 1 Myelodysplastic Syndromes 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia, Myeloid, Acute 1 Human Papillomavirus-Related Cervical Carcinoma 1 Human Papillomavirus-Related Carcinoma 1 Hematologic Neoplasms 1 HIV Infections 1 Condylomata Acuminata 1 Acquired Immunodeficiency Syndrome 1

Interventions

Specimen Handling 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Biopsy 3 Fluorouracil 2 Etoposide 2 Cyclophosphamide 2 liposomal doxorubicin 1 fludarabine 1 dehydroftorafur 1 carmustine, poliferprosan 20 drug combination 1 cabozantinib 1 axicabtagene ciloleucel 1 Zidovudine 1 X-Rays 1 Vincristine 1 Valganciclovir 1 Triage 1 Therapeutics 1 Standard of Care 1 Sodium Chloride 1 Smoking Devices 1 Sirolimus 1 Sigmoidoscopy 1 Sentinel Lymph Node Biopsy 1 Rituximab 1 Restraint, Physical 1 Raltegravir Potassium 1 Radiotherapy, Intensity-Modulated 1 Proctoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

HIV Infections × Human Papillomavirus Recombinant Vaccine nonavalent × 1 year × Clear all

NCT03284866 2026-01-28

COVENANT

AIDS Malignancy Consortium

Phase 3 Completed

HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡